Tag
Statins
33 genetic variants with this tag.
| RSID | Gene | Description | Category | ||
|---|---|---|---|---|---|
| rs11591147 | PCSK9 R46L | Loss-of-function variant that naturally lowers LDL cholesterol by 15-28% and ... | Atherogenic Lipoproteins | Established | |
| rs12487736 | SCAP SCAP Val798Ile | Missense variant in the SCAP cholesterol-sensor gene (Val798Ile); the C allel... | Atherogenic Lipoproteins | Moderate | |
| rs137852912 | PCSK9 D374Y | The most severe gain-of-function PCSK9 mutation, increasing LDLR-binding affi... | Atherogenic Lipoproteins | Established | |
| rs1125226 | CYP7A1 CYP7A1 upstream promoter variant | Upstream regulatory variant in CYP7A1 that tags haplotypes affecting bile aci... | Cholesterol & Lipoproteins | Emerging | |
| rs28942111 | PCSK9 S127R | Gain-of-function PCSK9 missense variant (Ser127Arg) causing autosomal dominan... | Atherogenic Lipoproteins | Established | |
| rs12721627 | CYP3A4 *16 | Missense variant reducing CYP3A4 enzyme activity by 50–74% depending on subst... | Pharmacogenomics | Moderate | |
| rs505151 | PCSK9 E670G | Common missense variant in PCSK9 exon 12 where the rare G allele raises LDL c... | Atherogenic Lipoproteins | Moderate | |
| rs12713559 | APOB APOB R3558C | Rare APOB missense variant reducing LDL-receptor binding affinity by ~40-50%,... | Cholesterol & Lipoproteins | Moderate | |
| rs137943601 | LDLR LDLR E408* (Glu408Ter) | Nonsense mutation in the LDLR gene creating a premature stop codon at positio... | Cholesterol & Lipoproteins | Strong | |
| rs20455 | KIF6 Trp719Arg | Missense variant in kinesin family member 6; the Arg allele was associated wi... | Coronary Artery Disease & Atherosclerosis | Moderate | |
| rs5925 | LDLR LDLR Expression Co-variant | Synonymous variant in LDLR exon 13 that modulates mRNA splicing efficiency in... | Atherogenic Lipoproteins | Moderate | |
| rs6008845 | PPARA PPARA intronic C/T | Regulatory PPARA variant where TT homozygotes with type 2 diabetes experience... | Atherogenic Lipoproteins | Strong | |
| rs185392267 | PCSK9 Arg96Cys | Gain-of-function missense variant in PCSK9 that increases intracellular LDL r... | Cholesterol & Lipoproteins | Strong | |
| rs6511720 | LDLR Intron 1 | Common regulatory variant in the LDL receptor gene affecting LDLR expression,... | Atherogenic Lipoproteins | Strong | |
| rs2228314 | SREBF2 SREBF2 G1784C | Missense variant in the master cholesterol transcription factor SREBP-2 that ... | Cholesterol & Lipoproteins | Moderate | |
| rs688 | LDLR Asn591Asn (c.1773C>T) | Synonymous LDLR variant that disrupts exon 12 splicing, reduces LDL receptor ... | Atherogenic Lipoproteins | Strong | |
| rs730882094 | LDLR Asn316Ser (N316S) | Rare likely-pathogenic missense variant in the LDLR EGF-like repeat domain ca... | Atherogenic Lipoproteins | Strong | |
| rs28942083 | LDLR Cys667Tyr | Pathogenic LDLR missense variant abolishing LDL receptor surface expression, ... | Cholesterol & Lipoproteins | Established | |
| rs730882105 | LDLR p.Val524Met | Rare LDLR missense variant (c.1570G>A, p.Val524Met) associated with familial ... | Atherogenic Lipoproteins | Moderate | |
| rs28942084 | LDLR LDLR Pro685Leu | Pathogenic LDLR missense variant in the EGF precursor domain causing familial... | Cholesterol & Lipoproteins | Established | |
| rs763625913 | LDLR Q770* (c.2308C>T) | Rare pathogenic nonsense variant in the LDL receptor gene that abolishes rece... | Atherogenic Lipoproteins | Established | |
| rs28942085 | LDLR LDLR Y828C (J.D. mutation) | Pathogenic LDLR missense variant (p.Tyr828Cys) that traps LDL receptors outsi... | Cholesterol & Lipoproteins | Established | |
| rs3846662 | HMGCR HMGCR Intron 13 Splice Variant | Intronic HMGCR variant that modulates alternative splicing of exon 13, produc... | Cholesterol & Lipoproteins | Moderate | |
| rs3846663 | HMGCR HMGCR Exon 13 Haplotype Tag | Intronic HMGCR variant that tags a haplotype influencing exon 13 alternative ... | Cholesterol & Lipoproteins | Strong | |
| rs2231142 | ABCG2 Q141K | Reduces ABCG2 transporter function affecting rosuvastatin levels and uric aci... | Pharmacogenomics | Established | |
| rs2242480 | CYP3A4 *1G | Intronic variant in CYP3A4 intron 10 that upregulates a suppressive lncRNA, r... | Pharmacogenomics | Strong | |
| rs673548 | APOB | Intronic APOB variant associated with modest differences in apolipoprotein B ... | Cholesterol & Lipoproteins | Moderate | |
| rs8192870 | CYP7A1 CYP7A1 intron 1 variant | Intronic variant in the rate-limiting bile acid synthesis gene; T allele carr... | Cholesterol & Lipoproteins | Moderate | |
| rs9818870 | MRAS | 3' UTR variant near miRNA binding sites in MRAS, associated with ~15% increas... | Coronary Artery Disease & Atherosclerosis | Strong | |
| rs35599367 | CYP3A4 *22 | Intronic splice variant causing ~50% reduced CYP3A4 mRNA expression, affectin... | Pharmacogenomics | Established | |
| rs4148323 | UGT1A1 *6 Gly71Arg | Phase II glucuronidation enzyme that metabolizes bilirubin and many drugs inc... | Pharmacogenomics | Established | |
| rs4149056 | SLCO1B1 *5 | Statin transport - affects muscle side effect risk with statins | Pharmacogenomics | Established | |
| rs55785340 | CYP3A4 *2 | Missense variant reducing CYP3A4-mediated nifedipine clearance, causing eleva... | Pharmacogenomics | Moderate |